Ca 21 channels and calmodulin (CaM) are two prominent signalling hubs 1 that synergistically affect functions as diverse as cardiac excitability 2 , synaptic plasticity 3 and gene transcription 4 . It is therefore fitting that these hubs are in some sense coordinated, as the opening of Ca V 1-2 Ca 21 channels are regulated by a single CaM constitutively complexed with channels 5 . The Ca 21 -free form of CaM (apoCaM) is already pre-associated with the isoleucineglutamine (IQ) domain on the channel carboxy terminus, and subsequent Ca 21 binding to this 'resident' CaM drives conformational changes that then trigger regulation of channel opening 6 . Another potential avenue for channel-CaM coordination could arise from the absence of Ca 21 regulation in channels lacking a pre-associated CaM 6,7 . Natural fluctuations in CaM concentrations might then influence the fraction of regulable channels and, thereby, the overall strength of Ca 21 feedback. However, the prevailing view has been that the ultrastrong affinity of channels for apoCaM ensures their saturation with CaM 8 , yielding a significant form of concentration independence between Ca 21 channels and CaM. Here we show that significant exceptions to this autonomy exist, by combining electrophysiology (to characterize channel regulation) with optical fluorescence resonance energy transfer (FRET) sensor determination of free-apoCaM concentration in live cells 9 . This approach translates quantitative CaM biochemistry from the traditional test-tube context into the realm of functioning holochannels within intact cells. From this perspective, we find that long splice forms of Ca V 1.3 and Ca V 1.4 channels include a distal carboxy tail 10-12 that resembles an enzyme competitive inhibitor that retunes channel affinity for apoCaM such that natural CaM variations affect the strength of Ca 21 feedback modulation. Given the ubiquity of these channels 13,14 , the connection between ambient CaM levels and Ca 21 entry through channels is broadly significant for Ca 21 homeostasis. Strategies such as ours promise key advances for the in situ analysis of signalling molecules resistant to in vitro reconstitution, such as Ca 21 channels.
f 50 = 0.67 ± 0.03 (5) f 50 = 0.15 ± 0.04 (7) C N EF IQ NSCaTE α 1DΔ a Figure 1 | Distal carboxy tail of Ca V 1.4 weakens Ca 21 regulation of channels. a, Core Ca V 1.3 channel contains all known structural elements required for CDI (schematic of main subunit a 1DD , containing NSCaTE 17 , EF 18 and IQ 6 ) and thereby exhibits robust CDI (subpanels). Average f 50 CDI metric shown at bottom (data shown, mean 6 s.e.m.), with number of cells in parentheses. Throughout, current scale bars pertain to Ca 21 currents. Ba 21 currents are scaled for kinetic comparison. Tail currents are clipped to frame. b, Adding DCT of a 1F (main pore-forming Ca V 1.4 subunit) to core Ca V 1.3 channel weakens CDI. A, B and ICDI segments of the a 1F DCT (together referred to as (ABI) F ) are defined in Supplementary Information, section 1.1. The dashed curve reproduces the baseline from a.
Hints of these consequences came from qualitative consideration of underlying mechanism. As background, we recapitulated coarse structural underpinnings of DCT effects. To confirm that DCT function requires complementary elements within core channels 11, 12 , we showed the lack of DCT effects on Ca V 2.2 channels (Supplementary Information, section 1.3), which presumably lack complementing modules. Furthermore 10, 12 , when such complementing modules are present, only ICDI and A subsegments of the DCT (Fig. 1b, left) are required for inhibition of CDI (Supplementary Information, section 1.4). Beyond these initial points, actual DCT mechanisms remain controversial. Glutathione S-transferase pull-downs of channel peptides have been used to support an allosteric mechanism (Supplementary Information, section 1.5), in which the ICDI associates with an EF-hand-like module to eliminate CDI transduction 12 (Fig. 1a, left) , but leaves apoCaM-channel binding unchanged. By contrast, in other work, channel peptide FRET has been used to advance a competitive mechanism (Supplementary Information, section 1.5) in which ICDI competes with apoCaM for binding near the channel IQ domain (Fig. 1a , left), thus inhibiting CDI by displacing CaM from channels 11 .
To help resolve this controversy, we pursued two preliminary approaches. First, using live-cell FRET two-hybrid assays 6, 17 we tested whether the Ca V 1.4 ICDI ( Fig. 2a , cyan fluorescent protein (CFP) fused to ICDI (ECFP-ICDI F )) could bind the presumed apoCaM pre-association module of Ca V 1.3 (yellow fluorescent protein (YFP) fused to the PreIQ 3 -IQ-A segment of the channel, as schematized in Figs 1b and 2a (EYFP-PreIQ 3 -IQ D -A F ); Supplementary Information, section 2.1). We thus resolved a high-affinity in situ binding curve ( Fig. 2a ) in which FRET strength (FR) is plotted cell-by-cell versus the concentration of free ECFP-ICDI F (D free , free donor). By contrast to previous analyses using single-number FRET indices 11 , our binding curve excludes low-affinity interaction, and a similar binding curve was obtained for partners solely derived from Ca V 1.4 (Supplementary Information, section 2.2). We also confirmed avid binding between apoCaM (ECFP-CaM WT in resting cells) and this EYFP-PreIQ 3 -IQ D -A F module 6 ( Fig. 2b ). More telling, the ICDI (without a fluorophore) attenuated the same apoCaM interaction ( Fig. 2c , grey zone), suggesting that ICDI and apoCaM could vie for IQ occupancy (Supplementary Fig. 2.2b ). Together, these data confirmed the potential for competition but pertained only to peptides, without guarantee of analogous events within intact channels.
Accordingly, a second provisional approach specifically targeted the holochannel configuration. Scrutiny of mechanisms (Supplementary Information, section 1.5) showed that manipulating apoCaM concentrations would affect CDI only in the competitive, but not strictly allosteric, framework. Indeed, increasing the CaM concentration sharply reversed ICDI effects ( Fig. 2d , middle), and apoCaM chelation eliminated residual CDI ( Fig. 2d , right; Supplementary Information, section 2.3). Notably, increasing the CaM concentration also increased the CDI of full-length Ca V 1.4 channels ( Fig. 2e ; but see ref. 19 ). Overall, both preliminary approaches supported competition, and the residual CDI seen earlier ( Fig. 1b ) appeared to reflect incomplete competition. Still, these data neither excluded more nuanced allosteric mechanisms 20 nor revealed whether biologically relevant CaM fluctuations could modulate CDI.
These limitations might be overcome if only the free-apoCaM concentration could be quantified within the same cells where CDI was measured. Then the holochannel equivalent of classic enzyme inhibition plots 20 , which rigorously distinguish among mechanisms, could be determined. Accordingly, we incorporated a recently developed optical FRET-based sensor of apoCaM, BSCaM IQ . Here CFP and YFP flank the apoCaM-binding site of neuromodulin 9 (Fig. 3a) , such that the overall FRET is determined by the free-apoCaM concentration. We confirmed the limiting behaviours by co-expressing BSCaM IQ with excess CaM (Fig. 3b , blue line) or CaMchelating peptides (Fig. 3b , green line (FR max ); Supplementary Information, section 3.1). As expected, FR was nearly independent of isolated CFP fluorescence, which is an approximate measure of sensor expression in each cell. By contrast, when BSCaM IQ was expressed alone, FR increased towards FR max (Fig. 3b , black line), as anticipated for a sensor that chelates and decreases free apoCaM. With reassurance of BSCaM IQ performance in our system, we coexpressed BSCaM IQ and Ca 21 channels, and measured the free-apoCaM concentration before determining CDI in the same cell ( Fig. 3c ). If free apoCaM were varied among cells by CaM overexpression or chelation, the resulting plot of CDI versus apoCaM would rigorously distinguish among mechanisms. Specifically, using the
e +10 mV f 300 = 0.01 ± 0.01 (5) Endogenous CaM relation between FRET and free-apoCaM concentration in our cells 9 (Supplementary Information, section 3.2), the exact signature of competition 20 becomes as shown in the right-hand plot of Fig. 3d (grey curves) and
where r 5 K d-channel-apparent /K d-sensor , CDI max is the maximal CDI without ICDI, K d-channel-apparent is the apparent dissociation constant of channels for apoCaM (with competitive inhibitor), K d-sensor is the dissociation constant of BSCaM IQ for apoCaM 9 (2.3 mM), and S b is the fraction of sensor bound to apoCaM (Supplementary Information, section 3.3). As Fig. 3b shows, S b is directly determined from FR and ranges from zero to one with increasing apoCaM. If ICDI competition is strong (r . 1), curves will be upwardly concave (right-hand plot of Fig. 3d , grey curves); if it is weak (r , 1), curves will be downwardly concave. Figure 3d also displays the experimental outcome for core Ca V 1.3 channels affixed to the Ca V 1.4 DCT (a 1DD -(ABI) F , from Fig. 1b ). In the CDI-S b plot, each symbol corresponds to a single cell, and together these data fit the competitive scheme (red curve; equation (1)) remarkably well. Current traces from exemplar cells (left-hand plots of Fig. 3d ; (i)-(iii)) explicitly demonstrate the appropriate increase of CDI with increasing S b and apoCaM concentration. Importantly, parallel analysis of core Ca V 1.3 channels revealed far greater apoCaM affinity (Fig. 3e ), yielding maximal CDI throughout. Hence, the upward concavity in Fig. 3d is a genuine ICDI effect, not an unanticipated property of the Ca V 1.3 core. Critically, at high apoCaM concentration (S b < 1), the CDIs of the two constructs converged, which is a hallmark of competition 20 .
Having established these results for the retinal Ca V 1.4 DCT, we wondered whether CDI-S b analysis might uncover similar DCT mechanisms in other Ca 21 channel subtypes, with yet broader distribution and impact. We considered a long splice variant of the human Ca V 1.3 channel 10 (a 1D-long[hum] ), which contains a DCT homologous to that in Ca V 1.4. This long variant has recently been reported to have decreased CDI 10 in comparison with a short variant akin to core channels (see, for example, Fig. 3e ). It thus seemed plausible that a competitive ICDI mechanism could extend to these channels, which would be an important possibility given the wide distribution of Ca V 1.3 channels 13, 14 and the predominance of the long variant throughout brain 10 . Complicating this view, however, were our prior observations that corresponding long and short variants of rat Ca V 1.3 channels show no difference in CDI 8 . Indeed, all of the experiments described to this point of the present study involved constructs based on rat Ca V 1.3 channels. Accordingly, we undertook CDI-S b analysis of long Ca V 1.3 variants from both human and rat. The human long Ca V 1.3 variant (Fig. 3f ) adhered to a competitive ICDI mechanism, with maximal CDI equivalent to that of core channels (compare Fig. 3f with Fig. 3e ). This suggests that long forms of Ca V 1.3 and Ca V 1.4 channels do share a common ICDI mechanism. However, the CDI-S b relation for the human long Ca V 1.3 variant differs quantitatively from that with the Ca V 1.4 DCT (compare Fig. 3f with Fig. 3d ), indicating that the strength of ICDI competition is customized according to channel isoform. Indeed, the rat long Ca V 1.3 variant showed extreme customization (Fig. 3g ). Here CDI-S b analysis unmasks competitive inhibition, but the competition is weak enough that CDI remains maximal, except with overt chelation of apoCaM (at S b < 0). The steep saturation of this CDI-S b relation thus explains prior data showing that CDI was unaffected by the rat Ca V 1.3 DCT, as no depletion was used 8 . Importantly, the CDI-S b curve for the rat long variant (Fig. 3g) is distinct from that for the Ca V 1.3 core (Fig. 3e) , where CDI stayed maximal throughout. Hence, the presence of rat Ca V 1.3 DCT entails customization, not elimination of the competitive inhibitory mechanism ( Supplementary Information, section 3.4) . The similarity of DCT elements, particularly of human and rat Ca V 1.3, suggested that minute differences produce extremes of tuning. Indeed, we found that a single valine-to-alanine switch within the ICDI explains the difference (human:rat, ICDI position 47; Supplementary Information, section 3.5).
Although the CDI-S b analysis established a competitive inhibitory mechanism at the holochannel level, still critically unresolved was whether the ICDI/IQ peptide interactions studied so far (Fig. 2c) were relevant to holochannel competition, especially given the multiplicity of CaM sites in channels 6, 17, 21, 22 . This is a generic challenge for large signalling complexes. Importantly, enzyme analysis could be extended to resolve even this ambiguity. Figure 4a summarizes our data for competitive inhibition in holochannels, recasting CDI-S b data into classic reciprocal-plot form 20 , where channel CDI (f 50 ) corresponds to enzyme catalytic velocity, V, and apoCaM corresponds to enzyme substrate concentration, S. Visual accord with the textbook signature of competition underscores the insights already provided by in situ holochannel biochemistry. Beyond this, if ICDI/IQ binding actually underlies holochannel competition, enzyme analysis additionally predicts a linear relation between the apparent apoCaM dissociation constant for holochannels (K d-channel-apparent ; equation (1)) and the reciprocal of the peptide dissociation constant (1/K d-FRET-peptide ):
Here K d-channel is the holochannel dissociation constant for apoCaM without inhibitor and [ICDI] is the effective concentration of ICDI at the channel pre-association site for apoCaM 20 ( Supplementary  Information, section 4.1) . Conversely, if peptide interactions are peripheral or the inhibitory mechanism not strictly competitive, this relation will probably fail ( Supplementary Information, section 4. 2). To test this prediction, we noted that CDI-S b analysis had already determined K d-channel-apparent for channels with three different ICDIs (Figs 3d, f, g and Fig. 4a ). Also, K d-FRET-peptide for the Ca V 1.4 ICDI was measured in Fig. 2a and the remaining K d-FRET-peptide values are deduced in Fig. 4b . The resulting linear plot (Fig. 4c) indicates that ICDI/IQ binding does underlie holochannel competition, and that apoCaM pre-association with channels involves the IQ domain with K d-channel < 10 nM ( Fig. 3e and Supplementary Information, section 4.1) . Transforming the reciprocal plots ( Fig. 4a ) into normal format raises diverse biological issues (Fig. 4d) . The dogma has been that Ca 21 channels have an ultrastrong apoCaM affinity 8 , ensuring maximal CDI over the natural range 23 (green), as confirmed for channels lacking ICDI (Fig. 4d, grey curve) . Earlier reports that ICDI simply 'switches off' CDI 11, 12 further promoted this perceived dissociation of CDI and apoCaM fluctuations. By contrast, we show here that ICDI retunes CDI-[apoCaM] relations, such that natural variations of apoCaM modulate CDI and overall Ca 21 entry (Fig. 4d ). Such interconnection opens many new possibilities, given the widespread impact and distribution of Ca V 1.3 and Ca V 1.4 channels [13] [14] [15] , and the regulation of CaM 23 . For example, co-expressing neuromodulin (a biomolecule that affects synaptic growth/remodelling/plasticity and buffers apoCaM 24 ) with the long variant of human Ca V 1.3 channels decreases apoCaM concentration sufficiently to eliminate CDI and promote Ca 21 entry ( Fig. 4e and Supplementary Information, section 4.3) . This outcome may bear on schizophrenia, in which the concentration of hippocampal neuromodulin is decreased 25 . Moreover, neurodegenerative diseases are potentially associated with Ca 21 dysregulation and, thereby, altered apoCaM 26 . In Parkinson's disease, excess a-synuclein is pathogenic 27 , these molecules bind apoCaM 28 , and elevated substantia nigral Ca V 1.3 activity predisposes for disease 29 . In Alzheimer's disease, CaM is depleted 26 . More broadly, certain models of heart failure feature increased CaM 30 . In all, exploring the physiological and pathophysiological sequelae of Ca 21 channel connectivity with CaM is now an important frontier of research.
METHODS SUMMARY
Molecular biology. We made channel chimaeras, mutants and CFP/YFP-tagged FRET constructs using standard molecular biological techniques. Detailed strategies for engineering various constructs are detailed in Methods. Transfection of HEK293 cells. We transiently expressed channels in HEK293 cells using established Ca 21 -phosphate-based procedures 6, 8 . Whole-cell electrophysiology. We performed whole-cell recordings in HEK293 cells at room temperature (20-22 uC) on an Axopatch 200A amplifier (Axon Instruments). The series resistance was 1-3 MV, before series resistance compensation of 80%. P/8 leak subtraction was used throughout. We low-pass filtered current records at 2 kHz and digitized them at rates several times greater. Detailed experimental conditions are described at length in Methods. FRET optical imaging. We carried out FRET two-hybrid experiments in HEK293 cells and analysed them as previously described 6 . During imaging, the bath solution was either a Tyrode's buffer containing 2 mM Ca 21 or the standard electrophysiological-recording bath solution. Concentration-dependent spurious FRET was subtracted from the raw data before binding-curve analysis 17 .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
